Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: Possible role of PDGF

Cardiovascular Drugs and Therapy

Volumn 12, Issue 3, 1998, Pages 251-260

  Miyauchi, Katsumi ^a   Aikawa, Masanori ^a,b   Tani, Takeshi ^c   Nakahara, Ken Ichi ^b   Kawai, Sachio ^a   Nagai, Ryozo ^b   Okada, Ryozo ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tokushima Research Institute   (Japan)

Author keywords

Antioxidant; Dedifferentiation; Intimal hyperplasia; PDGF; Platelet derived growth factor

Indexed keywords

ALPHA ACTIN; CYCLINE; MESSENGER RNA; MYOSIN HEAVY CHAIN; PLATELET DERIVED GROWTH FACTOR A; PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER; TIME;

ANGIOPLASTY, BALLOON; ANIMALS; ANTICHOLESTEREMIC AGENTS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL DIFFERENTIATION; CELL DIVISION; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; MYOSIN HEAVY CHAINS; PLATELET-DERIVED GROWTH FACTOR; PROBUCOL; PROTEIN ISOFORMS; RABBITS; RNA, MESSENGER;

EID: 0031697467     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007761631674     Document Type: Article

References (37)

1. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med 1990;88:1N-16N.
2. Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary angioplasty: New standards for clinical studies. J Am Coll Cardiol 1990;15:491-498.
3. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-1387.
4. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991;84:1426-1436
5. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanism. J Am Coll Cardiol 1992;20:1284-1293
6. Lee YJ, Yamaguchi H, Daida H, et al. PTCA: Pharmacological interventions to modify restenosis (abstr). Circulation 1991;84:II-298.
7. Kisanuki A, Asada Y, Hatakeyama K, Hayashi T, Sumiyoshi A. Contribution of the endothelial to intimal thickening in normocholesterolemic and hypercholesterolemic rabbits. Arterioscler Thromb 1992;88:628-637
8. Shinomiya M, Shirai K, Saito Y, Yoshida S. Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol. Atherosclerosis 1992;97:143-148
9. Ferns GAA, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Anggard EE. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci 1992;89:11312-11316
10. Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidant in restenosis. Circulation 1993;88:628-637
11. Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL. Inhibition of IL-1 β expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 1991;86:261-270
12. Ku G, Doherty NS, Schmidt LF, Jackson RL, Dinerstein RJ. Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties. FASEB J 1990;4:1645-1653
13. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990;67:651-659
14. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 1991;83:1327-1332
15. Kuro-o M, Nagai R, Nakahara K, et al. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and expression during vascular development and in arteriosclerosis. J Biol Chem 1991;266:3768-3773
16. Nagai R, Kuro-o M, Babij P, Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 1989;264:9734-9737.
17. Kuro-o M, Nagai R, Tsuchimochi H, et al. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 1989;264:18272-18275
18. Hedin U, Thyberg J. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to the synthetic phenotype. Differentiation 1987;33:239-346
19. Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988;107:307-319
20. Weissberg PL, Grainger DJ, Shanahan CM, Metcalfe JC. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovascular Res 1993;27:1191-1198
21. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500
22. Mao SJT, Yates MT, Rechtin AE, Jackson RL, Van Sickle WA. Antioxidant activity of probucol and its analogies in hypercholesterolemic Watanabe rabbits. J Med Chem 1991; 34:299-302
23. Kim HS, Aikawa M, Kimura K, et al. Ductus arteriosus: Advanced differentiation of smooth muscle cell demonstrated by myosin heavy chain isoform expression in rabbits. Circulation 1993;88:1804-1810
24. Anderson PG. Restenosis: Animal models and morphometric techniques in studies of the vascular response to injury. Cardiovasc Pathol 1992;1:263-278.
25. Chomezynski P, Saccini N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987;162:156-159
26. Nakahara K, Nishimura H, Kuro-o M, et al. Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem Biophys Res Commun 1992;184:811-818
27. Aikawa M, Sivam PN, Kuro-o M, et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993;73:1000-1012
28. Sabath D, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 1990;91:185-191.
29. Godfried SL, Deckelbaum LI. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1995;129:203-210
30. Simons M, Leclerc G, Safian RD, Isner JM, Weir L, Baim DS. Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N Engl J Med 1993;328:608-613
31. Suzuki J, Isobe M, Aikawa M, et al. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts. Circulation 1996;94:1118-1124
32. Kurki P, Ogata K, Tan EM. Monoclonal antibodies to proliferating cell nuclear antigen PCNA/cyclin as probes for proliferating cells by immunofluorecence microscopy and flow cytometry. J Immunol Methods 1988;109:49-55
33. Majesky MW, Reidy MA, Bowen Pope DF, Hart CE, Wicox JN, Schwarz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111:2149-2158
34. Ross R, Glomset JA. The pathogenesis of atherosclerosis (part 2). N Engl J Med 1976;295:420-425
35. Ku G, Doherty NS, Wolos JA, Jackson RL, Schmidt LF, Hendricks D. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol 1988;62:77B-81B
36. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblast and smooth muscle cell is due to PDGF-AA. Science 1989;243:393-396
37. Powell JS, Clozel JP, Muller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188